Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2310]
News [3024]
Articles [343]
Editorials [54]
Conferences [199]
elearning [126]
Personalised medicine differs from precision medicine
Prof Christine Chomienne - INCa, Paris, France
Personalised medicine differs from precision medicine ( Prof Christine Chomienne - INCa, Paris, France )
11 Dec 2017
Approaches to screening and early detection across Europe
Tit Albreht - Institute of Public Health, Ljubliana, Slovenia
Approaches to screening and early detection across Europe ( Tit Albreht - Institute of Public Health, Ljubliana, Slovenia )
11 Dec 2017
Connecting personalised medicine research in Canada with Europe
Dr Etienne Richer - CIHR Institute of Genetics, Montreal, Canada
Connecting personalised medicine research in Canada with Europe ( Dr Etienne Richer - CIHR Institute of Genetics, Montreal, Canada )
11 Dec 2017
Roche joining forces to forward precision oncology
Ian Walker - Roche Foundation Medicine, Basel, Switzerland
Roche joining forces to forward precision oncology ( Ian Walker - Roche Foundation Medicine, Basel, Switzerland )
11 Dec 2017
Cancer Core Europe
Prof Fabien Calvo - Institute Gustav Roussy, Paris, France
Cancer Core Europe ( Prof Fabien Calvo - Institute Gustav Roussy, Paris, France )
11 Dec 2017
Effective implementation of personalised medicine guidelines
Prof James N'Dow - European Association of Urology (EAU), Arnhem, The...
Effective implementation of personalised medicine guidelines ( Prof James N'Dow - European Association of Urology (EAU), Arnhem, The Netherlands )
11 Dec 2017
The significance of CEACAM 5 in metastases of triple negative breast cancer
Emily Powell - MD Anderson Cancer Center, Houston, USA
The significance of CEACAM 5 in metastases of triple negative breast cancer ( Emily Powell - MD Anderson Cancer Center, Houston, USA )
9 Dec 2017
The REACT trial: Celecoxib vs placebo for primary breast cancer
Prof Charles Coombes - Imperial College School of Medicine, London, UK
The REACT trial: Celecoxib vs placebo for primary breast cancer ( Prof Charles Coombes - Imperial College School of Medicine, London, UK )
9 Dec 2017
Rationale and recruitment in the PARTNER trial
Dr Jean Abraham - University of Cambridge, Cambridge, UK
Rationale and recruitment in the PARTNER trial ( Dr Jean Abraham - University of Cambridge, Cambridge, UK )
9 Dec 2017
The role of axiliary node dissection in modern breast cancer surgery
Dr Viviana Galimberti - European Institute of Oncology, Milan, Italy
The role of axiliary node dissection in modern breast cancer surgery ( Dr Viviana Galimberti - European Institute of Oncology, Milan, Italy )
9 Dec 2017
ER positive breast cancer: Screening for clinical variables to predict late...
Dr Ivana Sestak - Queen Mary University of London, London, UK
ER positive breast cancer: Screening for clinical variables to predict late distance disease recurrence ( Dr Ivana Sestak - Queen Mary University of London, London, UK )
9 Dec 2017
Predicting late breast cancer recurrence with screening assays
Prof Jack Cuzick - Wolfson Institute of Prevention Medicine, London, UK
Predicting late breast cancer recurrence with screening assays ( Prof Jack Cuzick - Wolfson Institute of Prevention Medicine, London, UK )
9 Dec 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation